US NUCLEAR CORP. (UCLE)
About US NUCLEAR CORP.
US NUCLEAR CORP
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2024
- $2.2M
- Net income
- -$1.7M
- Total assets
- $2.6M
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
US Nuclear Corp. (UCLE) Stock Price
- Reported a net loss of $1.7M in FY2024.
- Trading 79% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review US NUCLEAR CORP..
Write a review
US Nuclear Corp.: frequently asked questions
Is US Nuclear Corp. an American company?
US Nuclear Corp. is a US-based company headquartered in Canoga Park, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is US Nuclear Corp. headquartered?
US Nuclear Corp. is headquartered in Canoga Park, California, United States.
Is US Nuclear Corp. publicly traded?
Yes — US Nuclear Corp. is a publicly traded company. Its stock trades under the ticker symbol UCLE on the OTC.
What does US Nuclear Corp. do?
US Nuclear Corp. is an American Medical Devices company in the Health & Beauty sector.
